Cargando…

Primary hepatic angiosarcoma with noncirrhotic portal hypertension: A case report

BACKGROUND: Primary hepatic angiosarcoma (PHA) is a rare malignant tumor of mesothelial tissue origin in the liver. The diagnosis of PHA relies on pathology, and it is frequently misdiagnosed as multiple hepatic hemangioma. Noncirrhotic portal hypertension is a relatively rare pathological manifesta...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Xuwei, Yu, Xia, Gan, Qiaorong, Wang, Bin, Lin, Zhaowang, Shi, Yu, Huang, Zuxiong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9932891/
https://www.ncbi.nlm.nih.gov/pubmed/36816934
http://dx.doi.org/10.3389/fonc.2023.1037820
_version_ 1784889558007021568
author Wu, Xuwei
Yu, Xia
Gan, Qiaorong
Wang, Bin
Lin, Zhaowang
Shi, Yu
Huang, Zuxiong
author_facet Wu, Xuwei
Yu, Xia
Gan, Qiaorong
Wang, Bin
Lin, Zhaowang
Shi, Yu
Huang, Zuxiong
author_sort Wu, Xuwei
collection PubMed
description BACKGROUND: Primary hepatic angiosarcoma (PHA) is a rare malignant tumor of mesothelial tissue origin in the liver. The diagnosis of PHA relies on pathology, and it is frequently misdiagnosed as multiple hepatic hemangioma. Noncirrhotic portal hypertension is a relatively rare pathological manifestation, and there are few reports of PHA as an uncommon cause of noncirrhotic portal hypertension. CASE SUMMARY: A 36-year-old male was admitted with abnormal liver function and suspected drug-induced liver injury (DILI), initially manifesting as multifocal hepatic hemangioma. The liver biopsy revealed features of noncirrhotic portal hypertension (NCPH), and the patient was eventually diagnosed with multifocal hepatic angiosarcoma. CONCLUSION: Patients with PHA may present with NCPH in the liver due to injury to hepatic sinusoids; therefore, it is necessary to consider the possibility of unsampled vascular malignancy when hepatic masses are identified, and the histology is consistent with PHA.
format Online
Article
Text
id pubmed-9932891
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-99328912023-02-17 Primary hepatic angiosarcoma with noncirrhotic portal hypertension: A case report Wu, Xuwei Yu, Xia Gan, Qiaorong Wang, Bin Lin, Zhaowang Shi, Yu Huang, Zuxiong Front Oncol Oncology BACKGROUND: Primary hepatic angiosarcoma (PHA) is a rare malignant tumor of mesothelial tissue origin in the liver. The diagnosis of PHA relies on pathology, and it is frequently misdiagnosed as multiple hepatic hemangioma. Noncirrhotic portal hypertension is a relatively rare pathological manifestation, and there are few reports of PHA as an uncommon cause of noncirrhotic portal hypertension. CASE SUMMARY: A 36-year-old male was admitted with abnormal liver function and suspected drug-induced liver injury (DILI), initially manifesting as multifocal hepatic hemangioma. The liver biopsy revealed features of noncirrhotic portal hypertension (NCPH), and the patient was eventually diagnosed with multifocal hepatic angiosarcoma. CONCLUSION: Patients with PHA may present with NCPH in the liver due to injury to hepatic sinusoids; therefore, it is necessary to consider the possibility of unsampled vascular malignancy when hepatic masses are identified, and the histology is consistent with PHA. Frontiers Media S.A. 2023-02-02 /pmc/articles/PMC9932891/ /pubmed/36816934 http://dx.doi.org/10.3389/fonc.2023.1037820 Text en Copyright © 2023 Wu, Yu, Gan, Wang, Lin, Shi and Huang https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Wu, Xuwei
Yu, Xia
Gan, Qiaorong
Wang, Bin
Lin, Zhaowang
Shi, Yu
Huang, Zuxiong
Primary hepatic angiosarcoma with noncirrhotic portal hypertension: A case report
title Primary hepatic angiosarcoma with noncirrhotic portal hypertension: A case report
title_full Primary hepatic angiosarcoma with noncirrhotic portal hypertension: A case report
title_fullStr Primary hepatic angiosarcoma with noncirrhotic portal hypertension: A case report
title_full_unstemmed Primary hepatic angiosarcoma with noncirrhotic portal hypertension: A case report
title_short Primary hepatic angiosarcoma with noncirrhotic portal hypertension: A case report
title_sort primary hepatic angiosarcoma with noncirrhotic portal hypertension: a case report
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9932891/
https://www.ncbi.nlm.nih.gov/pubmed/36816934
http://dx.doi.org/10.3389/fonc.2023.1037820
work_keys_str_mv AT wuxuwei primaryhepaticangiosarcomawithnoncirrhoticportalhypertensionacasereport
AT yuxia primaryhepaticangiosarcomawithnoncirrhoticportalhypertensionacasereport
AT ganqiaorong primaryhepaticangiosarcomawithnoncirrhoticportalhypertensionacasereport
AT wangbin primaryhepaticangiosarcomawithnoncirrhoticportalhypertensionacasereport
AT linzhaowang primaryhepaticangiosarcomawithnoncirrhoticportalhypertensionacasereport
AT shiyu primaryhepaticangiosarcomawithnoncirrhoticportalhypertensionacasereport
AT huangzuxiong primaryhepaticangiosarcomawithnoncirrhoticportalhypertensionacasereport